Blog

The Nelson Advisors team regularly advise and mentor students, guest lecture and speak at leading University Business Schools and Societies across the UK and Europe. Our team discuss and debate the latest trends in Digital Health, HealthTech, Health IT, Healthcare Cybersecurity, Healthcare AI with students, guests and faculty members. &nbsp;&nbsp; The Nelson Advisors team regularly advise and mentor students and speak at leading University Business Schools and Societies including: &nbsp; 1) University College London - Global Business School for Health2) Oxford University - Oxford Venture Capital Network3) University of Cambridge - Cambridge Judge Business School4) Oxford University - Oxford MedTech society5) &nbsp;IESE Business School, Barcelona - Healthcare Club6) University College London - Investment Society7) &nbsp;Amsterdam University Medical Center - Department of Medical Informatics8) University of Amsterdam - Amsterdam Public Health Research InstituteIf you would like to discuss Nelson Advisors partnering with your University Business School or Society, please email <a data-mce-href="mailto:lloyd@nelsonadvisors.co.uk" href="mailto:lloyd@nelsonadvisors.co.uk" title="lloyd@nelsonadvisors.co.uk" target="_blank" rel="noopener" data-mce-selected="inline-boundary">lloyd@nelsonadvisors.co.uk</a>

Nelson Advisors partnering with University Business Schools and Societies across Europe

Nelson Advisors has been invited to be a guest speaker at the Department of Medical Informatics at the Amsterdam University Medical Center.The Department of Medical Informatics (Klinische Informatiekunde) at Amsterdam UMC works in close collaboration with the Amsterdam Public Health (APH) research institute. Situated primarily at the AMC location in Amsterdam, the department sits at the intersection of information science, computer science, medicine, and public health.&nbsp;Many faculty members and researchers in Medical Informatics hold dual affiliations with APH, contributing heavily to APH research programs—particularly Digital Health and Methodology.Collaboration with Amsterdam Public Health (APH) APH is a joint research alliance bringing together Amsterdam UMC, Vrije Universiteit Amsterdam (VU), and the University of Amsterdam (UvA).Open Research Amsterdam Within APH, the Department of Medical Informatics plays a central role in:Digital Health Program: Co-leading initiatives in eHealth interventions, mobile health monitoring, and healthcare AI.Amsterdam UMC &nbsp; Methodology Program: Standardising statistical methods, epidemiological data models, and data governance for public health research. Primary Care &amp; Population Health: Utilizing large electronic health record (EHR) databases—such as the General Practice Database (GPD-ANHA)—to study disease prevalence and health outcomes across the Amsterdam region. Education &amp; Degree Programs The department is responsible for running several high-profile academic programs:Bachelor's &amp; Master's in Medical Informatics (Klinische Informatiekunde) at UvA / Amsterdam UMC. Post-Master's Program in Health Informatics for working healthcare professionals. PhD Trajectories covering healthcare AI, medical statistics, and data engineering.Source: <a href="https://www.amsterdamumc.org/en/organization/amsterdam-umc">https://www.amsterdamumc.org/en/organization/amsterdam-umc</a>

Nelson Advisors invited to be a guest speaker at the Department of Medical Informatics at the Amsterdam University Medical Center

Nelson Advisors have been invited to speak at the UCL Investment Society Conference 2026 taking place in Central London in October 2026.&nbsp;The UCL Investment Society (UCLIS) Finance Conference is the flagship annual event organised by the UCL Investment Society, one of the largest and oldest student-led finance events in the Europe, Middle East, and Africa (EMEA) region.Key Highlights Industry Keynotes &amp; Speaker Panels: High-profile keynotes and executive panels featuring leaders from global financial institutions like J.P. Morgan, Goldman Sachs, Morgan Stanley, Citi, and HSBC.&nbsp;Competitions &amp; Workshops: Interactive sessions including financial valuation workshops (DCF, comparable analysis) and practical stock pitch competitions (such as the Jefferies Stock Pitch).Recruitment &amp; Networking: Direct access to firm recruiters, alumni, and analysts for 1-on-1 networking to help delegates land Spring Weeks, summer internships, and graduate roles.Source: <a href="https://studentsunionucl.org/clubs-societies/investment-society" data-mce-href="https://studentsunionucl.org/clubs-societies/investment-society">https://studentsunionucl.org/clubs-societies/investment-society</a>UCL Investment Society Conference 2025The 17th edition of the UCL Finance Conference, organized by the UCL Investment Society (UCLIS), took place on October 24th 2025 at The Waldorf Hilton Hotel in Central London. It brought together 150 selected delegates, industry leaders, and alumni for a full day of keynotes, workshops, and high-impact networking.Conference Highlights &amp; Agenda 1. Keynote &amp; Industry Leaders The conference featured insightful talks on financial markets, leadership, and macro trends from senior leaders across top global firms:Stephen Paine – Global Head of Infrastructure &amp; Utilities, Deutsche Bank Michael Lavelle – Head of Banking, Capital Markets &amp; Advisory (UK &amp; Ireland), Citi Lia Larson – Partner &amp; Head of Investment Banking Client Service EMEA, Goldman Sachs Ardal Loh-Gronager – Managing Partner, Loh-Gronager Partners 2. Practical Competitions &amp; Interactive Sessions Jefferies Stock Pitch Competition: Delegates pitched live trade ideas and received feedback and guidance from Jefferies professionals. Division Deep Dives: In partnership with Barclays, students engaged directly with professionals spanning private banking, wealth management, capital markets, and corporate banking. 3. Alumni Panel The event featured a dedicated alumni discussion offering real-world career trajectory advice from recent UCL graduates working across bulge-bracket banks and buy-side firms.&nbsp;

Nelson Advisors invited to speak at the UCL Investment Society Conference 2026

The global financial advisory landscape for Healthcare Technology (HealthTech) and Medical Technology (MedTech) is undergoing a deep structural realignment, transitionally termed the "Great Rationalisation". This shift represents a departure from the liquidity-fuelled, growth at all costs environment that characterised the early 2020s, moving toward a highly disciplined, metrics-centric climate. In this matured market environment, enterprise valuation is no longer dictated by raw revenue expansion; instead, it is determined by clinical utility, regulatory resilience and integration into established clinical pathways. &nbsp;&nbsp; Consequently, traditional bulge bracket investment banking institutions are increasingly ceding the high-growth mid-market to a sophisticated tier of specialist boutique advisors. These specialised firms, led by founder-bankers with deep scientific literacy and operational empathy, are uniquely positioned to bridge the linguistic, operational and valuation gaps that often exist between agile technology founders and risk-averse institutional buyers. &nbsp;&nbsp; At the centre of this structural shift is Nelson Advisors LLP (Partnership Number: OC456267), a premier boutique investment bank exclusively dedicated to mergers, acquisitions, partnerships and strategic capital allocations across HealthTech, MedTech, Digital Health, Healthcare IT, FemTech, Healthcare Cybersecurity, and Healthcare AI. Based at Hale House, 76-78 Portland Place in Marylebone, London, the firm has established a highly differentiated "Founders for Founders" operational model.The Specialist Boutique and the Founder Banker Paradigm &nbsp;Specialist boutiques have emerged as primary liquidity engines for European innovation, typically focusing on transactions valued between $25 Million and $250 Million. Unlike traditional banks staffed by career financiers, founder-bankers possess direct operational experience derived from having personally built, scaled and exited clinical technology enterprises. This practitioner-led background is central to their advisory positioning, enabling them to translate early-stage consumer engagement metrics into the clinical validation required by risk-averse institutional buyers, thereby transforming administrative and regulatory hurdles into clear valuation drivers. &nbsp;&nbsp; The industry influence of these boutiques is demonstrated by the broad dissemination of their research. For instance, analysis originating from Nelson Advisors’ thought leadership platform, Healthcare.Digital, is frequently cited by global consultancies like Deloitte in life sciences M&amp;A updates, by intelligence platforms like Mergermarket in coverage of AI-driven MedTech dealmaking and by policy institutes such as the Tony Blair Institute for Global Change.Source: <a href="https://www.healthcare.digital/single-post/nelson-advisors-digital-health-m-a-advisory-and-lower-to-mid-market-investment-banking">https://www.healthcare.digital/single-post/nelson-advisors-digital-health-m-a-advisory-and-lower-to-mid-market-investment-banking</a> &nbsp;

Nelson Advisors: Digital Health M&A Advisory and Lower to Mid Market Investment Banking

England’s National Health Service is executing a major consolidation of its citizen-facing digital channels. This transition is shifting the system away from localised, fragmented patient engagement portals toward a centralised, national platform. Codified under the National Digital Channels Platform and Integration Strategy and accelerated by the "Fit for the Future" 10-Year Health Plan, the strategic goal is to establish the NHS App as the definitive "digital front door" to all health and social care services by 2028. This transition marks a fundamental structural shift in how patient communications, unplanned care triage and elective care pathways are administered across the health service. &nbsp;&nbsp; The scale of England’s national digital infrastructure provides a strong foundation for this consolidation. The NHS App maintains a registered user base of over 37.4 Million citizens, while NHS login has confirmed 43 Million accounts integrated across 71 distinct digital partners. Monthly active engagement is high, with approximately 27% of the population in England actively using the NHS App every month. Over the 2024 to 2025 period, monthly logins surged from 25 Million to over 50 Million, with NHS England establishing a target of 100 Million monthly logins. This national consolidation aims to address the historically low productivity of the NHS by reducing duplication of digital services, lowering "Did Not Attend" (DNA) rates, and driving a system-wide shift from reactive acute care to proactive, prevention-focused digital self-care.This digital consolidation builds upon successful regional models of shared records and patient-facing transparency. In London, the OneLondon partnership’s London Care Record has demonstrated the value of regional integration, connecting clinical information across acute, primary, and community settings. The London Care Record is accessed more than 2 Million times a month, yielding an estimated £4.6 Million in monthly staff time savings. &nbsp;&nbsp; By scaling these localised successes into a national infrastructure, the Department of Health and Social Care (DHSC) aims to dismantle the barriers that historically prevented the flow of clinical data across organisational boundaries. This strategy is designed to resolve the "productivity paradox" of NHS IT, where substantial historical capital investments in local technologies failed to yield system-wide efficiencies because they were deployed within isolated clinical silos.Click here to read the report in full - <a href="https://www.healthcare.digital/single-post/the-disintermediation-of-patient-portals-in-england-the-nhs-app-direct-epr-integrations-and-digita" data-mce-href="https://www.healthcare.digital/single-post/the-disintermediation-of-patient-portals-in-england-the-nhs-app-direct-epr-integrations-and-digita">https://www.healthcare.digital/single-post/the-disintermediation-of-patient-portals-in-england-the-nhs-app-direct-epr-integrations-and-digita</a>Nelson Advisors &gt; European MedTech and HealthTech Investment Banking &nbsp; &nbsp;Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies. <a href="http://www.nelsonadvisors.co.uk" data-mce-href="http://www.nelsonadvisors.co.uk">www.nelsonadvisors.co.uk</a>Nelson Advisors regularly publish Thought Leadership articles covering market insights, trends, analysis &amp; predictions @ <a href="https://www.healthcare.digital" data-mce-href="https://www.healthcare.digital">https://www.healthcare.digital&nbsp;</a>Nelson Advisors publish Europe’s leading HealthTech and MedTech M&amp;A Newsletter every week, subscribe today! <a href="https://lnkd.in/e5hTp_xb" data-mce-href="https://lnkd.in/e5hTp_xb">https://lnkd.in/e5hTp_xb&nbsp;</a>Nelson Advisors pride ourselves on our DNA as ‘Founders advising Founders.’ We partner with entrepreneurs, boards and investors to maximise shareholder value and investment returns. <a href="http://www.nelsonadvisors.co.uk" data-mce-href="http://www.nelsonadvisors.co.uk">www.nelsonadvisors.co.uk</a>#NelsonAdvisors #HealthTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #ConsumerHealthTech #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #VentureCapital #PrivateEquity #Founders #SeriesA #SeriesB #Founders #SellSide #TechAssets #Fundraising #BuildBuyPartner #GoToMarket #PharmaTech #BioTech #Genomics #MedTech &nbsp;Nelson Advisors LLP &nbsp; Hale House, 76-78 Portland Place, Marylebone, London, W1B 1NT<a href="mailto:lloyd@nelsonadvisors.co.uk">lloyd@nelsonadvisors.co.uk</a><a href="mailto:paul@nelsonadvisors.co.uk" data-mce-selected="inline-boundary">paul@nelsonadvisors.co.uk﻿</a>Meet Nelson Advisors @ 2026 Events &nbsp; &nbsp;Digital Health Rewired &gt; March 2026 &gt; Birmingham, UK&nbsp; &nbsp; NHS ConfedExpo &nbsp;&gt; June 2026 &gt; Manchester, UK&nbsp; &nbsp; HLTH Europe &gt; June 2026, Amsterdam, Netherlands &nbsp; HIMSS AI in Healthcare &gt; July 2026, New York, USA &nbsp; &nbsp;Bits &amp; Pretzels &gt; September 2026, Munich, Germany &nbsp; &nbsp; World Health Summit 2026 &gt; October 2026, Berlin, Germany &nbsp; &nbsp;HealthInvestor Healthcare Summit &gt; October 2026, London, UK&nbsp;HLTH USA 2026 &gt; October 2026, USA &nbsp; Barclays Health Elevate &gt; October 2026, London, UK&nbsp; &nbsp; Web Summit 2026 &gt; November 2026, Lisbon, Portugal &nbsp; &nbsp; &nbsp;MEDICA 2026 &gt; November 2026, Düsseldorf, Germany &nbsp; &nbsp;Venture Capital World Summit &gt; December 2026 Toronto, Canada

The NHS App, Direct EPR Integrations and Digital Front Door Strategy: The Disintermediation of Patient Portals in England

On July 13th, 2026, VitalHub Corp. completed the acquisition of Buddy Healthcare Ltd Oy, a Helsinki-based care coordination and patient engagement software developer. The transaction is structured to align the incentives of the target's founders and management team with VitalHub’s long-term corporate growth objectives. The total upfront consideration of €8.6 Million comprises €8.3 Million in cash, subject to standard post-closing working capital adjustments and the issuance of 75,000 common shares of VitalHub. &nbsp;&nbsp; To protect the acquirer from integration risk while incentivising post-merger operational execution, the deal includes an all-cash performance-based earn out structure of up to €4.5 Million, payable at the end of the first two calendar years post-acquisition. As of June 30th, 2026, Buddy Healthcare reported an Annual Recurring Revenue (ARR) of approximately €2.8 Million and was operating at approximately Adjusted EBITDA breakeven. &nbsp;&nbsp; VitalHub executed this transaction from a position of financial strength. As of March 31st, 2026, VitalHub maintained a highly liquid balance sheet, reporting a current ratio of 3.25, holding more cash than debt, and possessing $121.3 Million USD in cash, cash equivalents, and short-term investments. &nbsp;&nbsp; While certain market reports have cited a $2.1 Billion revenue figure, verified corporate filings indicate a more accurate trailing twelve-month (TTM) revenue of $86.2 Million USD as of March 31, 2026 and CA$119.20 Million. This clarifies that Buddy Healthcare's €2.8 Million ARR constitutes a highly digestible but strategically significant bolt-on acquisition representing roughly 3% to 4% of VitalHub's consolidated top-line revenue.Click here to read the report in full - <a href="https://www.healthcare.digital/single-post/strategic-analysis-of-vitalhub-s-acquisition-of-buddy-healthcare-restructuring-patient-flow-and-cli" data-mce-href="https://www.healthcare.digital/single-post/strategic-analysis-of-vitalhub-s-acquisition-of-buddy-healthcare-restructuring-patient-flow-and-cli">https://www.healthcare.digital/single-post/strategic-analysis-of-vitalhub-s-acquisition-of-buddy-healthcare-restructuring-patient-flow-and-cli</a>Nelson Advisors &gt; European MedTech and HealthTech Investment Banking &nbsp; &nbsp;Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies. <a href="http://www.nelsonadvisors.co.uk">www.nelsonadvisors.co.uk</a>Nelson Advisors regularly publish Thought Leadership articles covering market insights, trends, analysis &amp; predictions @ <a href="https://www.healthcare.digital">https://www.healthcare.digital</a>Nelson Advisors publish Europe’s leading HealthTech and MedTech M&amp;A Newsletter every week, subscribe today! <a href="https://lnkd.in/e5hTp_xb">https://lnkd.in/e5hTp_xb&nbsp;</a>Nelson Advisors pride ourselves on our DNA as ‘Founders advising Founders.’ We partner with entrepreneurs, boards and investors to maximise shareholder value and investment returns. <a href="http://www.nelsonadvisors.co.uk">www.nelsonadvisors.co.uk</a>#NelsonAdvisors #HealthTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #ConsumerHealthTech #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #VentureCapital #PrivateEquity #Founders #SeriesA #SeriesB #Founders #SellSide #TechAssets #Fundraising #BuildBuyPartner #GoToMarket #PharmaTech #BioTech #Genomics #MedTech &nbsp;Nelson Advisors LLP &nbsp; Hale House, 76-78 Portland Place, Marylebone, London, W1B 1NT<a href="mailto:lloyd@nelsonadvisors.co.uk">lloyd@nelsonadvisors.co.uk</a><a href="mailto:paul@nelsonadvisors.co.uk">paul@nelsonadvisors.co.uk</a>Meet Nelson Advisors @ 2026 Events &nbsp; &nbsp;Digital Health Rewired &gt; March 2026 &gt; Birmingham, UK&nbsp; &nbsp; NHS ConfedExpo &nbsp;&gt; June 2026 &gt; Manchester, UK&nbsp; &nbsp; HLTH Europe &gt; June 2026, Amsterdam, Netherlands &nbsp; HIMSS AI in Healthcare &gt; July 2026, New York, USA &nbsp; &nbsp;Bits &amp; Pretzels &gt; September 2026, Munich, Germany &nbsp; &nbsp; World Health Summit 2026 &gt; October 2026, Berlin, Germany &nbsp; &nbsp;HealthInvestor Healthcare Summit &gt; October 2026, London, UK&nbsp;HLTH USA 2026 &gt; October 2026, USA &nbsp; Barclays Health Elevate &gt; October 2026, London, UK&nbsp; &nbsp; Web Summit 2026 &gt; November 2026, Lisbon, Portugal &nbsp; &nbsp; &nbsp;MEDICA 2026 &gt; November 2026, Düsseldorf, Germany &nbsp; &nbsp;Venture Capital World Summit &gt; December 2026 Toronto, Canada &nbsp;

Nelson Advisors

Blog

Nelson Advisors partnering with University Business Schoo...

Nelson Advisors invited to be a guest speaker at the Depa...

Nelson Advisors invited to speak at the UCL Investment So...

Nelson Advisors: Digital Health M&A Advisory and Lower to...

The NHS App, Direct EPR Integrations and Digital Front Do...

Restructuring Patient Flow and Clinical Pathway Automatio...